Barinthus Biotherapeutics (BRNS) Free Cash Flow (2020 - 2026)
Barinthus Biotherapeutics (BRNS) free cash flow from Mar 31, 2020 to Mar 31, 2026. The TTM Barinthus Biotherapeutics (BRNS) free cash flow is -$36M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Barinthus Biotherapeutics (BRNS) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +11.87% |
| 3 Years TTM | +25.22% |
| 5 Years TTM | +18.90% |
| All Time TTM | +18.90% |
Annual Free Cash Flow change of Barinthus Biotherapeutics (BRNS)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$3.37M | -92.98% |
| 2025 | -$48M | +60.98% |
| 2024 | -$30M | -47.04% |
| 2023 | -$56M | +173.85% |
| 2022 | -$21M | -39.02% |
| 2021 | -$34M | +197.97% |
| 2020 | -$11M | N/A |
Comparison Barinthus Biotherapeutics (BRNS) five years free cash flow CAGR with competitors
Barinthus Biotherapeutics (BRNS) five years free cash flow CAGR is 18.92%.